The goal of this pilot randomized controlled trial is to compare pain relief efficacy while using nasal packing versus greater palatine foramen block (GPFB) in the management of acute episodes of epistaxis. The main questions it aims to answer are: Does GPFB have less potential to inflict pain when dealing with hemostasis with epistaxis, utilizing a pre-validated 10-point visual analog scale (VAS)? Was hemostasis management more effective in either technique? Researchers will compare anterior nasal packing to greater palatine foramen block using 2% xylocaine with adrenaline.
Patients will receive any of the hemostatic interventions at the time of the acute epistaxis episode.
The questionnaire will be administered 24 hours post-intervention.
Presentation with active anterior epistaxis
Failure of initial conservative measures (e.g., nasal compression and topical vasoconstrictors)
Ability to provide informed consent and those who consent for the study.
Suspected or confirmed posterior epistaxis
Known bleeding disorders or platelet count <50,000/mm³
Use of anticoagulants with supratherapeutic INR
Known allergy to local anaesthetic agents
Parallel
Greater Palatine Foramen Block with 2% xylocaine with adrenaline
Procedure/SurgeryPatients allocated to this group will receive a greater palatine foramen block using a local anaesthetic agent (2% i.e. 20mg/dL Inj. Lidocaine with adrenaline) administered at the greater palatine foramen under aseptic conditions. Patients will be monitored for local anaesthetic as well as GPF block-related adverse effects. Hemostasis will be assessed following the procedure.
Anterior Nasal Packing
Procedure/SurgeryPatients allocated to this group will receive anterior nasal packing using standard non-absorbable nasal packs following institutional protocol. Packs will remain in situ for 24-72 hours, unless earlier removal is clinically indicated.
● Pain intensity measured
using the 10-point Visual Analog Scale (VAS) for the interventions mentioned
● Successful control of epistaxis
defined as cessation of bleeding within 10 minutes of intervention without the need for additional procedures
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
